financetom
Business
financetom
/
Business
/
Air Products Activist Investor Mantle Ridge Introduces 4 Director Nominees, CEO Candidate
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Air Products Activist Investor Mantle Ridge Introduces 4 Director Nominees, CEO Candidate
Jan 7, 2025 8:40 AM

11:16 AM EST, 01/07/2025 (MT Newswires) -- Air Products and Chemicals ( APD ) activist investor Mantle Ridge on Tuesday introduced four director nominees to the company's board and its proposed chief executive candidate, Eduardo Menezes, through a series of video interviews.

Mantle Ridge, which said it owns $1.3 billion in Air Products shares, urged investors to vote for its nominees "to enhance Air Products' performance and create the long-term value that shareholders deserve."

Air Products issued a statement Tuesday saying its board is undertaking "a rigorous CEO succession plan."

"The board has clearly articulated a CEO succession plan to ensure a smooth transition between [Seifi] Ghasemi and his successor and has committed to providing an announcement of a new president and related timeline for CEO succession no later than March 31," the company said.

Air Products didn't immediately respond to a request for comment from MT Newswires regarding Mantle Ridge's statement.

The company's shares were more than 3% higher in recent trading.

Price: 290.21, Change: +6.97, Percent Change: +2.46

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - Spirent Communications PLC
Form 8.3 - Spirent Communications PLC
Sep 17, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Canopy Growth Appoints Tom Stewart as Finance Chief
Canopy Growth Appoints Tom Stewart as Finance Chief
Sep 17, 2025
07:48 AM EDT, 09/17/2025 (MT Newswires) -- Canopy Growth Corporation ( CGC ) said Wednesday that Tom Stewart has been appointed chief financial officer, effective immediately. He has worked as interim CFO since July and has been part of Canopy Growth's ( CGC ) senior finance team since 2019, contributing to initiatives like debt repayments and capital raising, the company...
Microbix Client Labquality Launching External Quality Assessment Scheme For Head and Neck Cancers
Microbix Client Labquality Launching External Quality Assessment Scheme For Head and Neck Cancers
Sep 17, 2025
07:50 AM EDT, 09/17/2025 (MT Newswires) -- Life sciences company Microbix Biosystems ( MBXBF ) and Finnish company Labquality on Wednesday announced an external quality assessment (EQA) program to help clinical laboratories accurately identify head and neck cancers (HNC) associated with cancer-causing strains of the human papilloma virus (HPV). A pilot EQA study was conducted earlier this year involving 32...
Regeneron Pharmaceuticals' Phase 3 Trial of Garetosmab in Fibrodysplasia Ossificans Progressiva Meets Primary Endpoint
Regeneron Pharmaceuticals' Phase 3 Trial of Garetosmab in Fibrodysplasia Ossificans Progressiva Meets Primary Endpoint
Sep 17, 2025
07:48 AM EDT, 09/17/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) said Wednesday its phase 3 study of garetosmab in adults with fibrodysplasia ossificans progressiva, or FOP, met its primary endpoint, demonstrating a greater reduction in new bone lesions compared with placebo. The company said the trial enrolled 63 people with FOP aged at least 18 years old. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved